EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Congenital insensitivity to pain with anhidrosis: a literature review and the advocacy for stem cell therapeutic interventions

Muhammad Ikrama iD, Muhammad Usama, Muhammad Hassan Haider, Shifa Israr, Maryam Humayon

Therapeutic Advances in Rare Disease · 2024-01 · 5

DOI: 10.1177/26330040241292378 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Rare Disease, online erschienen am 31.10.2024. Verfasst von Muhammad Ikrama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Services Institute of Medical Sciences, Jail Road, Lahore 54000, Pakistan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital Insensitivity to Pain with Anhidrosis (CIPA) is a rare genetic disorder affecting the autonomic nervous system, leading to an inability to feel pain, temperature, or sweat1. This condition is caused by mutations in the NTRK1 gene, which encodes a receptor for nerve growth factor (NGF). The lack of NGF signaling results in the improper development and function of sensory and sympathetic neurons. Patients with CIPA often suffer from repeated injuries, infections, and hyperthermia due to their inability to sense pain and regulate body temperature. Management focuses on preventing injuries, controlling infections, and providing supportive care, as there is no definitive cure for CIPA. We present several hypotheses for treating CIPA using stem cells and modern genetic techniques. One approach involves using induced pluripotent stem cells (iPSCs) to replace defective neurons. Another hypothesis suggests in vivo gene editing of neural progenitors to restore TrkA function. Additionally, mesenchymal stem cells (MSCs) genetically modified to overexpress NGF could provide trophic support. Other strategies include epigenetic modulation of NTRK1 expression and exosome-mediated gene therapy. These innovative approaches aim to address the underlying genetic defects and restore normal cellular functions in CIPA patients.

Schlagwörter

Stichwörter der Autor:innen

CIPAHSAN type IVcongenital insensitivity to pain with anhidrosiscongenital sensory neuropathiesstem cells

Autor:innen und Institutionen

  • Services Institute of Medical Sciences, Jail Road, Lahore 54000, Pakistan.
  • Services Institute of Medical Sciences, Lahore, Pakistan.

ORCID-Profile: Muhammad Ikrama

Zitieren

APA

Ikrama, M., Usama, M., Haider, M. H., Israr, S., & Humayon, M. (2024). Congenital insensitivity to pain with anhidrosis: a literature review and the advocacy for stem cell therapeutic interventions. Therapeutic Advances in Rare Disease, 5. https://doi.org/10.1177/26330040241292378

Vancouver

Ikrama M, Usama M, Haider MH, Israr S, Humayon M. Congenital insensitivity to pain with anhidrosis: a literature review and the advocacy for stem cell therapeutic interventions. Therapeutic Advances in Rare Disease. 2024;5. doi:10.1177/26330040241292378

BibTeX
@article{Ikrama2024,
  author = {Ikrama, Muhammad and Usama, Muhammad and Haider, Muhammad Hassan and Israr, Shifa and Humayon, Maryam},
  title = {Congenital insensitivity to pain with anhidrosis: a literature review and the advocacy for stem cell therapeutic interventions},
  journal = {Therapeutic Advances in Rare Disease},
  year = {2024},
  volume = {5},
  doi = {10.1177/26330040241292378}
}
Kostenlos starten →